SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known whether SU-101 is more effective than
procarbazine in treating patients with glioblastoma multiforme.
PURPOSE: Randomized phase III trial to compare the effectiveness of SU-101 with that of
procarbazine in treating patients with glioblastoma multiforme that has recurred.